The Vanguard Group 13D and 13G filings for Merck & Co., Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-06 2:08 pm Purchase |
2025-02-28 | 13G | Merck & Co., Inc. MRK |
The Vanguard Group | 253,257,639 10.020% |
8,490,605 (+3.47%) |
Filing |
| 2024-02-13 4:55 pm Purchase |
2023-12-29 | 13G | Merck & Co., Inc. MRK |
The Vanguard Group | 244,767,034 9.660% |
17,561,056 (+7.73%) |
Filing |
| 2023-02-09 10:54 am Purchase |
2022-12-30 | 13G | Merck & Co., Inc. MRK |
The Vanguard Group | 227,205,978 8.960% |
16,003,447 (+7.58%) |
Filing |
| 2022-02-09 3:15 pm Sale |
2021-12-31 | 13G | Merck & Co., Inc. MRK |
The Vanguard Group | 211,202,531 8.360% |
-7,211,824 (-3.30%) |
Filing |
| 2021-02-10 10:02 am Sale |
2020-12-31 | 13G | Merck & Co., Inc. MRK |
The Vanguard Group | 218,414,355 8.240% |
-2,234,010 (-1.01%) |
Filing |